aTyr Pharma, Inc. - Common Stock (NQ:ATYR)
0.5452
+0.0152
(+2.87%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Aug 25, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 481,361 |
| Open | 0.5386 |
| Bid (Size) | 0.5452 (200) |
| Ask (Size) | 0.5614 (400) |
| Prev. Close | 0.5300 |
| Today's Range | 0.5322 - 0.5689 |
| 52wk Range | 0.3950 - 6.500 |
| Shares Outstanding | 54,291,754 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
What's going on in today's session ↗
May 14, 2026
Which stocks are moving on Tuesday? ↗
May 12, 2026
Top movers in Thursday's session ↗
January 29, 2026
Thursday's session: gap up and gap down stocks ↗
January 29, 2026
Which stocks are moving after the closing bell on Tuesday? ↗
December 02, 2025
Frequently Asked Questions
Is aTyr Pharma, Inc. - Common Stock publicly traded?
Yes, aTyr Pharma, Inc. - Common Stock is publicly traded.
What exchange does aTyr Pharma, Inc. - Common Stock trade on?
aTyr Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for aTyr Pharma, Inc. - Common Stock?
The ticker symbol for aTyr Pharma, Inc. - Common Stock is ATYR on the Nasdaq Stock Market
What is the current price of aTyr Pharma, Inc. - Common Stock?
The current price of aTyr Pharma, Inc. - Common Stock is 0.5452
When was aTyr Pharma, Inc. - Common Stock last traded?
The last trade of aTyr Pharma, Inc. - Common Stock was at 08/25/26 01:00 PM ET
What is the market capitalization of aTyr Pharma, Inc. - Common Stock?
The market capitalization of aTyr Pharma, Inc. - Common Stock is 29.60M
How many shares of aTyr Pharma, Inc. - Common Stock are outstanding?
aTyr Pharma, Inc. - Common Stock has 30M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.